What does Dr. Annerose Allemon do?

Dr. Annerose Allemon is a general practice in Antwerpen. Private Limited, started on 13 October 2022, 1 establishment.

What is the address of Dr. Annerose Allemon?

The registered office of Dr. Annerose Allemon is located at Lange Leemstraat 385, 2018 Antwerpen.

Is Dr. Annerose Allemon still active?

Yes. According to the CBE (5 October 2026) Dr. Annerose Allemon is active, legal situation “Normale toestand”, started on 13 October 2022.

Is Dr. Annerose Allemon registered on Peppol?

Yes, Dr. Annerose Allemon is registered on the Peppol network with ID 0208:0792439124.

What is the enterprise number of Dr. Annerose Allemon?

The enterprise number of Dr. Annerose Allemon is BE0792439124.

When was Dr. Annerose Allemon founded?

Dr. Annerose Allemon was founded on 13 October 2022.

Who are the directors of Dr. Annerose Allemon?

According to the 2025 annual accounts, the directors of Dr. Annerose Allemon are: Annerose Allemon.

Is Dr. Annerose Allemon a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 October 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Annerose Allemon make in 2025?

Dr. Annerose Allemon recorded a loss after taxes of € 2,443 in financial year 2025.

What is the revenue of Dr. Annerose Allemon?

As a small company, Dr. Annerose Allemon is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -1,660.

Dr. Annerose Allemon (Private Limited) - Antwerpen

Dossier Dr. Annerose Allemon, printed on 5 October 2026 from databakkes.be/en/0792439124/dr-annerose-allemon. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Annerose Allemon from Antwerpen, company number BE0792439124, closed financial year 2025 with a result of € -2,443 after tax. For that financial year Dr. Annerose Allemon recorded a gross margin of € -1,660 and equity of € 16,447. Compared with financial year 2024, the result moved from € 14,756 to € -2,443. The company made a loss. The buffer shrank hard: equity is 70 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Shrank hard

€ 16,447

▼ 70% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -2,443

▼ still € 14,756 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 21,523

▼ 45% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 15,447.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 706

▼ 76% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 26,239 Gross margin 2022: € 26,239 First fiscal year in the series	€ 29,199 Gross margin 2023: € 29,199 ▲ 11% vs 2022 (€ 26,239) Favourable step	€ 20,517 Gross margin 2024: € 20,517 ▼ 30% vs 2023 (€ 29,199) Unfavourable step	€ -1,660 Gross margin 2025: € -1,660 ▼ € 22,176 vs 2024 (€ 20,517) Unfavourable step	▼ € 22,176
Profit after taxes	€ 17,890 Profit after taxes 2022: € 17,890 First fiscal year in the series	€ 20,389 Profit after taxes 2023: € 20,389 ▲ 14% vs 2022 (€ 17,890) Favourable step	€ 14,756 Profit after taxes 2024: € 14,756 ▼ 28% vs 2023 (€ 20,389) Unfavourable step	€ -2,443 Profit after taxes 2025: € -2,443 ▼ € 17,200 vs 2024 (€ 14,756) Unfavourable step	▼ € 17,200
Equity	€ 18,890 Equity 2022: € 18,890 First fiscal year in the series	€ 39,279 Equity 2023: € 39,279 ▲ 108% vs 2022 (€ 18,890) Favourable step	€ 54,036 Equity 2024: € 54,036 ▲ 38% vs 2023 (€ 39,279) Favourable step	€ 16,447 Equity 2025: € 16,447 ▼ 70% vs 2024 (€ 54,036) Unfavourable step	▼ 70%
Total debts	€ 7,186 Total debts 2022: € 7,186 First fiscal year in the series	€ 3,536 Total debts 2023: € 3,536 ▼ 51% vs 2022 (€ 7,186) Favourable step	€ 5,328 Total debts 2024: € 5,328 ▲ 51% vs 2023 (€ 3,536) Unfavourable step	€ 16,020 Total debts 2025: € 16,020 ▲ 201% vs 2024 (€ 5,328) Unfavourable step	▲ 201%
Cash	€ 19,804 Cash 2022: € 19,804 First fiscal year in the series	€ 31,184 Cash 2023: € 31,184 ▲ 57% vs 2022 (€ 19,804) Favourable step	€ 39,081 Cash 2024: € 39,081 ▲ 25% vs 2023 (€ 31,184) Favourable step	€ 21,523 Cash 2025: € 21,523 ▼ 45% vs 2024 (€ 39,081) Unfavourable step	▼ 45%
Retained profit	€ 17,890 Retained profit 2022: € 17,890 First fiscal year in the series	€ 38,279 Retained profit 2023: € 38,279 ▲ 114% vs 2022 (€ 17,890) Favourable step	€ 53,036 Retained profit 2024: € 53,036 ▲ 39% vs 2023 (€ 38,279) Favourable step	€ 15,447 Retained profit 2025: € 15,447 ▼ 71% vs 2024 (€ 53,036) Unfavourable step	▼ 71%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 35,145 Dividend 2025: € 35,145 Unchanged (€ 0) Unchanged
Balance sheet total	€ 26,076 Balance sheet total 2022: € 26,076 First fiscal year in the series	€ 42,815 Balance sheet total 2023: € 42,815 ▲ 64% vs 2022 (€ 26,076) Unchanged	€ 59,363 Balance sheet total 2024: € 59,363 ▲ 39% vs 2023 (€ 42,815) Unchanged	€ 32,468 Balance sheet total 2025: € 32,468 ▼ 45% vs 2024 (€ 59,363) Unchanged	▼ 45%

Key figures of Dr. Annerose Allemon, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Annerose Allemon?

What happened at Dr. Annerose Allemon in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 8, 2026 New annual accounts for financial year 2025: loss of € 2,443 (▼ € 17,200 vs 2024). Source: NBB ↗
Oct 13, 2022 New establishment in Antwerpen. KBO
2022 Annerose Allemon became a director. NBB
Oct 13, 2022 Start of the company according to the CBE. KBO

In short

From € 17,890 profit in 2022 to € 2,443 loss in 2025.

Paid € 19,099 in corporate taxes since 2022.

Best year ever: 2023, with € 20,389 profit.

Paid out € 35,145 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Annerose Allemon? We notify you, reason included.

Follow Dr. Annerose Allemon

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Annerose Allemon

Dr. Annerose Allemon

Behind Dr. Annerose Allemon is Annerose Allemon.

See the full network in the app

Directors

According to the 2025 annual accounts

Annerose Allemon

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Lange Leemstraat 385

2018 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Medisch Huis Lange Leem 385

IMMO LL 385

€ 60,165 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0792.439.124
VAT number: BE 0792.439.124
Registered office: Lange Leemstraat 385, 2018 Antwerpen
Names & denominations: Dr. Annerose Allemon
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 October 2022
Peppol: Active · Active since 4 Nov 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗